Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors

M Sanchez-Cespedes1, P Parrella, S Nomoto

  • 1Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.

Cancer Research
|October 5, 2001
PubMed

Insights

Mitochondrial DNA (mtDNA) mutations at the D310 locus are common in tumors. These D310 alterations, present in normal cells, become concentrated in tumors via genetic drift and clonal expansion.

Area of Science:

  • Mitochondrial genetics
  • Cancer biology
  • Molecular oncology

Background:

  • Mitochondrial DNA (mtDNA) mutations are observed in various cancers.
  • The origins and roles of mtDNA mutations in tumorigenesis remain largely unknown.

Purpose of the Study:

  • To identify specific mtDNA mutation hotspots in primary tumors.
  • To investigate the mechanisms and implications of mutations in the D310 region of mtDNA.

Main Methods:

  • Analysis of mtDNA from 247 primary tumors and preneoplastic lesions.
  • Sequencing of D310 variants in lung and head and neck cancers.
  • Quantification of D310 heteroplasmy in patient lymphocytes.

Main Results:

  • The D310 homopolymeric C stretch in the mtDNA displacement loop is a mutational hotspot.
  • Somatic deletions/insertions at D310 were found in 22% of primary tumors and preneoplastic lesions.
  • Tumor-associated D310 variants often matched pre-existing polymorphisms; higher lymphocyte heteroplasmy correlated with tumor mutations.

Conclusions:

  • The D310 region is a significant mutational hotspot in cancer development.
  • mtDNA D310 alterations may originate in normal cells and become fixed in tumors through genetic drift and clonal expansion.